Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes.
OBJECTIVE
To assess the extent of teaching about the Committee on Safety of Medicine's Yellow Card scheme and adverse drug reactions within UK Schools of Medicine and Pharmacy.


METHODS
A self-completed questionnaire sent to all heads of undergraduate schools of medicine and pharmacy within the UK.


RESULTS
The majority of undergraduate syllabi feature the Yellow Card Scheme. Knowledge of the Yellow Card Scheme was assessed in 79% of pharmacy programmes and 57% of medical schools. Specialist speakers on the Yellow Card Scheme were infrequently used. Fewer than half of respondents provided students with a guide to reporting ADRs (43% pharmacy and 43% medical). There is some disagreement about the value of supplying students with printed material about the Yellow Card Scheme. Half of medical Schools did not think that supplying 'Current Problems In Pharmacovigilance' would be useful.


CONCLUSIONS
It was found that in both medicine and pharmacy, courses differed substantially in teaching about the Yellow Card Scheme and adverse drug reactions (ADRs). There is scope for increased involvement of the Medicines and Healthcare products Regulatory Agency in undergraduate education, in line with recommendations from the National Audit Office.
Cox
A R
AR
West Midlands Centre for Adverse Drug Reaction Reporting, City Hospital NHS Trust, Birmingham, UK. coxar@aston.ac.uk
Marriott
J F
JF
Wilson
K A
KA
Ferner
R E
RE
D016907:Adverse Drug Reaction Reporting Systems; D003479:Curriculum; D004504:Education, Medical, Undergraduate; D004512:Education, Pharmacy; D006801:Humans; D006113:United Kingdom